Author | John V. Heymach, MD, PhD | OncLive

Author | John V. Heymach, MD, PhD

Articles

Dr. Heymach on the Significance of Nivolumab for Lung Cancer

June 02, 2017

Video

John V. Heymach, MD, PhD, chairman, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, discusses the significance of nivolumab (Opdivo) for patients with lung cancer.

Dr. Heymach on Nivolumab for Lung Cancer

April 14, 2017

Video

John V. Heymach, MD, PhD, chairman, Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, discusses efficacy findings with nivolumab (Opdivo) results for patients with metastatic lung cancer.

x